312 related articles for article (PubMed ID: 29797540)
21. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
[TBL] [Abstract][Full Text] [Related]
22. [Expression of sB7-H4 in Serum and Lymphoma Tissues of Patients with Malignant Lymphoma and Its Value for Diagnosis and Re-Examine of Lymphoma].
Liang XP; Yang HL; Shao MM; Li N; Li XF; Liu B; Li HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1355-1359. PubMed ID: 30295250
[TBL] [Abstract][Full Text] [Related]
23. [Relationships between concentrations of free fatty acid in serum and oxidative-damage levels in placental mitochondria and preeclampsia].
Yan JY; Xu X
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):412-7. PubMed ID: 22932105
[TBL] [Abstract][Full Text] [Related]
24. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
[TBL] [Abstract][Full Text] [Related]
25. Reduced Placental CD24 in Preterm Preeclampsia Is an Indicator for a Failure of Immune Tolerance.
Sammar M; Siwetz M; Meiri H; Sharabi-Nov A; Altevogt P; Huppertz B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360811
[TBL] [Abstract][Full Text] [Related]
26. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
[TBL] [Abstract][Full Text] [Related]
27. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
Ong CY; Liao AW; Cacho AM; Spencer K; Nicolaides KH
Obstet Gynecol; 2001 Oct; 98(4):608-11. PubMed ID: 11576576
[TBL] [Abstract][Full Text] [Related]
28. Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection.
Qiu F; Yuan C; Xu J; Zhang J; Chen F; Liu D; Zheng B; Li R; Huang X; Xu J
J Biomed Nanotechnol; 2019 May; 15(5):1043-1051. PubMed ID: 30890234
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of serum soluble B7-H4 in acute pancreatitis.
Cheng Z; Liu Z; Yuan Y; Liu Z; He Y; Jiang P
Eur J Clin Invest; 2020 Dec; 50(12):e13346. PubMed ID: 32648937
[TBL] [Abstract][Full Text] [Related]
30. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
31. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes.
Dieber-Rotheneder M; Beganovic S; Desoye G; Lang U; Cervar-Zivkovic M
Life Sci; 2012 Oct; 91(13-14):710-5. PubMed ID: 22580289
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases.
Ding S; Zhou H; Gu Y; Shen Y; Zhang L; Zhao H; Wu J; Zhang X; Chang X; Liu C
Clin Exp Immunol; 2021 Aug; 205(2):150-159. PubMed ID: 33961296
[TBL] [Abstract][Full Text] [Related]
33. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
[TBL] [Abstract][Full Text] [Related]
34. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum levels and placental expression of hepcidin in preeclampsia.
Cardaropoli S; Todros T; Nuzzo AM; Rolfo A
Pregnancy Hypertens; 2018 Jan; 11():47-53. PubMed ID: 29523273
[TBL] [Abstract][Full Text] [Related]
36. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
37. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
[TBL] [Abstract][Full Text] [Related]
38. Serum soluble LIGHT in the early third trimester as a novel biomarker for predicting late-onset preeclampsia.
Hirashima C; Ohmaru-Nakanishi T; Nagayama S; Takahashi K; Suzuki H; Takahashi H; Usui R; Shirasuna K; Matsubara S; Ohkuchi A
Pregnancy Hypertens; 2018 Oct; 14():174-176. PubMed ID: 30527108
[TBL] [Abstract][Full Text] [Related]
39. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.
Manuelpillai U; Schneider-Kolsky M; Dole A; Wallace EM
J Endocrinol; 2001 Oct; 171(1):57-64. PubMed ID: 11572790
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
Xu CH; Yu LK
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
